QC Kinetix is a center for regenerative medicine treatments offering non-surgical pain management therapies. Through the latest in regenerative medicine therapies and techniques, QC Kinetix helps patients effectively achieve the solutions they seek. Regenerative medicine is the next great frontier in medical treatment, and QC Kinetix is helping to lead the charge. Our franchisees benefit from a strong brand reputation, committed leadership, control over the way they practice medicine, and innovative, impactful treatment modalities. Our board-certified providers and regenerative medicine solutions offer a rejuvenating experience that will vastly improve our clientele’s quality of life.
QC Kinetix is the place to go when you’ve been told invasive surgery is your best option, or after you’ve tried everything to eliminate the pain and immobility of your condition without success. We provide comprehensive regenerative medicine injection treatments, including stem cell therapy with BMAC, regenerative cell therapy with amniotic membrane tissue, A2M therapy and PRP therapy. With such a wide array of regenerative medicine treatments available, we make sure to discuss all the therapeutic options with each of our patients. While not all patients may be candidates for all therapies, we help guide them to make the most appropriate decisions for their particular condition. We treat everyone from weekend warriors and professional athletes to aging patients who want to stay active. We are dedicated to maximizing the body’s ability to help heal and repair itself from the inside out for vastly improved function and overall quality of life, without surgery, steroids, or reliance on pain medications.
QC Kinetix is currently the only regenerative medicine franchise group and is growing rapidly across the country. With no medical background needed, our franchise owners are business people from all walks of life who are looking to invest in a profitable business model, diversify their portfolio, and be involved in the future of medicine.